[1]
|
Wollina, U. (2019) Is Rosacea a Systemic Disease? Clinics in Dermatology, 37, 629-635.
https://doi.org/10.1016/j.clindermatol.2019.07.032
|
[2]
|
Ahn, C.S. and Huang, W.W. (2018) Rosacea Pathogenesis. Dermatologic Clinics, 36, 81-86.
https://doi.org/10.1016/j.det.2017.11.001
|
[3]
|
Wollina, U. (2014) Recent Advances in the Understanding and Management of Rosacea. F1000 Medicine Reports, 6, 50. https://doi.org/10.12703/P6-50
|
[4]
|
Berg, M. and Liden, S. (1989) An Epidemiological Study of Rosacea. Acta Dermato-Venereologica, 69, 419-423.
|
[5]
|
Parisi, R. and Yiu, Z.Z.N. (2018) The Worldwide Epidemiology of Rosacea. British Journal of Dermatology, 179, 239-240.
|
[6]
|
Wang, Y., Zhao, Z., Liu, F., et al. (2020) Relationship between the Incidence of Rosacea and Drinking or Smoking in China. Journal of Central South University. Medical Sciences, 45, 165-168.
|
[7]
|
Gallo, R.L., Granstein, R.D., Kang, S., Man-nis, M., Steinhoff, M., Tan, J. and Thiboutot, D. (2018) Standard Classification and Pathophysiology of Rosacea: The 2017 Update by the National Rosacea Society Expert Committee. Journal of the American Academy of Dermatology, 78, 148-155. https://doi.org/10.1016/j.jaad.2017.08.037
|
[8]
|
Johnson, S.M., Berg, A. and Barr, C. (2020) Managing Rosacea in the Clinic: From Pathophysiology to Treatment—A Review of the Literature. The Journal of Clinical and Aesthetic Dermatology, 13, S17-S22.
|
[9]
|
Wilkin, J., Dahl, M., Detmar, M., et al. (2004) Standard Grading System for Rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. Journal of the American Academy of Dermatology, 50, 907-912. https://doi.org/10.1016/j.jaad.2004.01.048
|
[10]
|
Rosso, J.D. (2012) Advances in Understanding and Managing Rosacea: Part 1: Connecting the Dots between Pathophysiological Mechanisms and Common Clinical Features of Rosacea with Emphasis on Vascular Changes and Facial Erythema. Journal of Clinical & Aesthetic Dermatology, 5, 16-25.
|
[11]
|
Two, A.M. and Del Rosso, J.Q. (2014) Kallikrein 5-Mediated Inflammation in Rosacea: Clinically Relevant Correlations with Acute and Chronic Manifestations in Rosacea and How Individual Treatments May Provide Therapeutic Benefit. Journal of Clinical & Aesthetic Dermatology, 7, 20-25.
|
[12]
|
潘廷猛, 陈雪路, 施雯, 荣光辉, 何彩凤. 羟氯喹联合多西环素序贯光电协同治疗I型及II型玫瑰痤疮临床观察[J]. 中国美容医学, 2020, 29(9): 22-26.
|
[13]
|
Schaller, M., Almeida, L., Bewley, A., et al. (2017) Rosacea Treatment Update: Recommendations from the Global ROSacea COnsensus (ROSCO) Panel. British Journal of Der-matology, 176, 465-471.
https://doi.org/10.1111/bjd.15173
|
[14]
|
Kim, J.H., Oh, Y.S. and Choi, E.H. (2011) Oral Azithromycin for Treat-ment of Intractable Rosacea. Journal of Korean Medical Science, 26, 694-696. https://doi.org/10.3346/jkms.2011.26.5.694
|
[15]
|
Rezaković, S., Mokos, Z.B. and Paštar, Z. (2015) Pyridoxine In-duced Rosacea-Like Dermatitis. Acta Clinica Croatica, 54, 99-102.
|
[16]
|
Lee, G.L. and Zirwas, M.J. (2015) Granulom-atous Rosacea and Periorificial Dermatitis. Dermatologic Clinics, 33, 447-455. https://doi.org/10.1016/j.det.2015.03.009
|
[17]
|
赵旭明, 温杰, 吴远慧, 等. 低剂量异维A酸治疗难治性丘疹脓疱型玫瑰痤疮的临床疗效[J]. 中国中西医结合皮肤性病学杂志, 2021, 20(6): 557-560.
|
[18]
|
徐晓静, 朱元杰. 不同剂量异维A酸联合脉冲染料激光治疗酒渣鼻的疗效及安全性分析[J]. 中国美容医学, 2021, 30(1): 73-76.
|
[19]
|
Wang, B., Yuan, X., Huang, X., et al. (2021) Efficacy and Safety of Hydroxychloroquine for Treatment of Patients with Rosacea: A Multicenter, Randomized, Double-Blind, Double-Dummy, Pilot Study. Journal of the American Academy of Dermatology, 84, 543-545. https://doi.org/10.1016/j.jaad.2020.05.050
|
[20]
|
Schaller, M., Almeida, L.M., Bewley, A., Cribier, B., et al. (2017) Rosacea Treatment Update: Recommendations from the Global ROSacea COnsensus (ROSCO) Panel. British Journal of Dermatology, 176, 465-471.
https://doi.org/10.1111/bjd.15173
|
[21]
|
刘乐, 陈文慧. 羟氯喹联合盐酸多西环素治疗玫瑰痤疮疗效观察[J]. 中国中西医结合皮肤性病学杂志, 2020, 19(5): 431-432.
|
[22]
|
Guiguemde, W., Shelat, A., Garcia-Bustos, J., et al. (2012) Global Phenotypic Screening for Antimalarials. Chemistry & Biology, 19, 116-129. https://doi.org/10.1016/j.chembiol.2012.01.004
|
[23]
|
Schaller, M., Almeida, L.M.C., Bewley, A., Cribier, B., et al. (2020) Recommendations for Rosacea Diagnosis, Classification and Management: Update from the Global Rosacea Consensus 2019 Panel. British Journal of Dermatology, 182, 1269-1276. https://doi.org/10.1111/bjd.18420
|
[24]
|
Hsu, C.C. and Lee, J.Y. (2011) Carvedilol for the Treatment of Refractory Facial Flushing and Persistent Erythema of Rosacea. Archives of Dermatology, 147, 1258-1260. https://doi.org/10.1001/archdermatol.2011.204
|
[25]
|
Pietschke, K. and Schaller, M. (2017) Long-Term Management of Distinct Facial Flushing and Persistent Erythema of Rosacea by Treatment with Carvedilol. Journal of Dermatological Treatment, 29, 310-313.
https://doi.org/10.1080/09546634.2017.1360991
|
[26]
|
Seo, B.H., Dong, H.K., Suh, H.S., et al. (2020) Facial Flushing and Erythema of Rosacea Improved by Carvedilol. Dermatologic Therapy, 33, e14520.
|
[27]
|
van Zuuren, E.J., Fedorowicz, Z., Tan, J., van der Linden, M.M.D., Arents, B.W.M., Carter, B. and Charland, L. (2019) Interventions for Rosacea Based on the Phenotype Approach: An Updated Systematic Review Including GRADE Assessments. British Journal of Dermatology, 181, 65-79. https://doi.org/10.1111/bjd.17590
|
[28]
|
Coda, A.B., Hata, T., Miller, J., et al. (2013) Cathelicidin, Kallikrein 5, and Serine Protease Activity Is Inhibited during Treatment of Rosacea with Azelaic Ac-id 15% Gel. Journal of the American Academy of Dermatology, 69, 570-577.
https://doi.org/10.1016/j.jaad.2013.05.019
|
[29]
|
Nakagawa, H., Nemoto, O., Igarashi, A., Saeki, H., Kabashima, K., Oda, M. and Nagata, T. (2021) Delgocitinib Ointment in Pediatric Patients with Atopic Dermatitis: A Phase 3, Random-ized, Double-Blind, Vehicle-Controlled Study and a Subsequent Open-Label, Long-Term Study. Journal of the American Academy of Dermatology, 85, 854-862.
https://doi.org/10.1016/j.jaad.2021.06.014
|
[30]
|
Starosta, D.A. and Lorenz, B. (2021) Pediatric Ocular Rosacea Ef-fectively Treated with Topical 1.5% Azithromycin Eye Drops. Der Ophthalmologe, 118, 68-73. https://doi.org/10.1007/s00347-020-01279-z
|
[31]
|
Husein-El Ahmed, H. and Steinhoff, M. (2020) Efficacy of Top-ical Ivermectin and Impact on Quality of Life in Patients with Papulopustular Rosacea: A Systematic Review and Me-ta-Analysis. Dermatologic Therapy, 33, e13203.
https://doi.org/10.1111/dth.13203
|
[32]
|
Trave, I., Merlo, G., Cozzani, E., et al. (2019) Real-Life Experience on Ef-fectiveness and Tolerability of Topical Ivermectin in Papulopustular Rosacea and Antiparasitic Effect on Demodex Mites. Dermatologic Therapy, 32, e13093.
https://doi.org/10.1111/dth.13093
|
[33]
|
Aronson, I.K., Rumsfield, J.A., West, D.P., et al. (1987) Evaluation of Topical Metronidazole Gel in Acne Rosacea. Drug Intelligence & Clinical Pharmacy, 21, 346-351. https://doi.org/10.1177/106002808702100410
|
[34]
|
Nielsen, P.G. (1983) Treatment of Rosacea with 1% Metroni-dazole Cream. A Double-Blind Study. British Journal of Dermatology, 108, 327-332. https://doi.org/10.1111/j.1365-2133.1983.tb03972.x
|
[35]
|
Maddin, S. (1999) A Comparison of Topical Azelaic Acid 20% Cream and Topical Metronidazole 0.75% Cream in the Treatment of Patients with Papulopustular Rosacea. Journal of the American Academy of Dermatology, 40, 961-965.
https://doi.org/10.1016/S0190-9622(99)70085-X
|
[36]
|
Elewski, B.E., Fleischer, A.B. and Pariser, D.M. (2019) A Comparison of 15% Azelaic Acid Gel and 0.75% Metronidazole Gel in the Topical Treatment of Papulopustular Rosacea Results of a Randomized Trial.
https://doi.org/10.1001/archderm.139.11.1444
|
[37]
|
Shemer, A., Shiri, J., Mashiah, J., et al. (2016) Topical Mino-cycline Foam for Moderate to Severe Acne Vulgaris: Phase 2 Randomized Double-Blind, Vehicle-Controlled Study Re-sults. Journal of the American Academy of Dermatology, 74, 1251-1252. https://doi.org/10.1016/j.jaad.2015.09.065
|
[38]
|
Gold, L.S., Del Rosso, J.Q., Kircik, L., et al. (2020) Minocycline 1.5% Foam for the Topical Treatment of Moderate to Severe Papulopustular Rosacea: Results of 2 Phase 3, Randomized, Clinical Trials. Journal of the American Academy of Dermatology, 82, 1166-1173. https://doi.org/10.1016/j.jaad.2020.01.043
|
[39]
|
Webster, G., Draelos, Z.D., Graber, E., et al. (2020) A Multicentre, Randomized, Double-Masked, Parallel Group, Vehicle-Controlled Phase IIb Study to Evaluate the Safety and Efficacy of 1% and 3% Topical Minocycline Gel in Patients with Papulopustular Rosacea. British Journal of Dermatology, 183, 471-479. https://doi.org/10.1111/bjd.18857
|
[40]
|
Zuuren, E.J.V., Fedorowicz, Z., Tan, J., et al. (2019) Evi-dence-Based Treatments for Rosacea Based on Phenotype Approach. British Journal of Dermatology, 181, e16. https://doi.org/10.1111/bjd.18064
|
[41]
|
Kim, B.Y., Moon, H.R. and Ryu, H.J. (2019) Comparative Efficacy of Short-Pulsed Intense Pulsed Light and Pulsed Dye Laser to Treat Rosacea. Journal of Cosmetic and Laser Therapy, 21, 291-296.
https://doi.org/10.1080/14764172.2018.1528371
|
[42]
|
Liu, J., Liu, J., Ren, Y., et al. (2014) Comparative Efficacy of Intense Pulsed Light for Different Erythema Associated with Rosacea. Journal of Cosmetic and Laser Therapy, 16, 324-327. https://doi.org/10.3109/14764172.2014.957218
|
[43]
|
Zhang, Y., Jiang, S., Lu, Y., et al. (2020) A Decade Retrospective Study of Light/Laser Devices in Treating Nasal Rosacea. Journal of Dermatological Treatment, 31, 84-90. https://doi.org/10.1080/09546634.2019.1580669
|
[44]
|
Friedmann, D.P., Goldman, M.P., Fabi, S.G., et al. (2018) Comparison of Efficacy between Long-Pulsed Nd:YAG Laser and Pulsed Dye Laser to Treat Rosacea-Associated Nasal Telangiectasia. Journal of Cosmetic and Laser Therapy, 20, 260-264. https://doi.org/10.1080/14764172.2017.1418510
|
[45]
|
Lee, J.H., Na, S.Y., Choi, M., et al. (2012) Long-Pulsed Nd:YAG Laser: Does It Give Clinical Benefit on the Treatment of Resistant Telangiectasia? The Journal of the European Academy of Dermatology and Venereology, 26, 1280-1284.
https://doi.org/10.1111/j.1468-3083.2011.04282.x
|
[46]
|
中国医师协会皮肤科医师分会皮肤美容亚专业委员会. 中国玫瑰痤疮诊疗专家共识(2016) [J]. 中华皮肤科杂志, 2017, 50(3): 156-157.
|
[47]
|
赵梓刚, 李承新. 玫瑰痤疮的非药物治疗[J]. 皮肤病与性病, 2017, 40(2): 96-98.
|
[48]
|
Meesters, A.A., van der Linden, M.M. and De Rie, M.A. (2015) Fractionated Carbon Dioxide Laser Therapy as Treatment of Mild Rhinophyma: Report of Three Cases. Derma-tologic Therapy 28, 147-150.
https://doi.org/10.1111/dth.12205
|
[49]
|
Orenstein, A., Haik, J., Tamir, J., et al. (2001) Treatment of Rhinophyma with Er:YAG Laser. Lasers in Surgery and Medicine, 29, 230-235. https://doi.org/10.1002/lsm.1112
|
[50]
|
Tanghetti, E.A., Goldberg, D.J., Dover, J.S., Geronemus, R.G., Bai, Z., Al-vandi, N. and Shanler, S.D. (2021) Oxymetazoline and Energy-Based Therapy in Patients with Rosacea: Evaluation of the Safety and Tolerability in an Open-Label, Interventional Study. Lasers in Surgery and Medicine, 53, 55-65. https://doi.org/10.1002/lsm.23253
|
[51]
|
Suggs, A.K., Macri, A., Richmond, H., Munavalli, G. and Friedman, P.M. (2020) Treatment of Erythematotelangiectatic Rosacea with Pulsed-Dye Laser and Oxymetazoline 1.0% Cream: A Retro-spective Study. Lasers in Surgery and Medicine, 52, 38-43. https://doi.org/10.1002/lsm.23176
|
[52]
|
方方, 张国成. 协和皮肤外科学[M]. 北京: 中国协和医科大学出版社, 2008: 124-125.
|